Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.78 USD | -1.35% | +14.62% | +51.97% |
May. 13 | Janney Starts TScan Therapeutics With Buy Rating, $11 Price Target | MT |
May. 13 | TScan Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+51.97% | 509M | |
+33.22% | 50.85B | |
+0.70% | 42.82B | |
+49.62% | 42.03B | |
-4.96% | 29.55B | |
+10.88% | 26.11B | |
-21.78% | 19.13B | |
+8.98% | 13.05B | |
+27.42% | 12.16B | |
+23.80% | 12.08B |
- Stock Market
- Equities
- TCRX Stock
- News TScan Therapeutics, Inc.
- TScan Therapeutics Names Jason Amello as Finance Chief